ARPA-H-SOL-24-103: Resilient Systems Office: Office-Wide Innovative Solutions Opening for Advanced Research Projects Agency for Health
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Advanced Research Projects Agency for Health notices from 2024.
Advanced Research Projects Agency for Health offered grants to nonprofits, colleges and universities, tribes, small businesses and businesses. It expected to make about 100 awards. Applications closed on March 14, 2025.
From the official notice on Grants.gov, last changed March 26, 2024. Checked November 7, 2026.
- Expected awards100
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeCooperative Agreement, Other
Key dates
| Posted | March 14, 2024 |
|---|---|
| Deadline | March 14, 2025 |
| Archived by Grants.gov | April 13, 2025 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, tribes, small businesses and businesses.
All 7 applicant types the notice lists
- Public and State controlled institutions of higher education
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
Is this a realistic fit?
- Most of the program's money (96% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
This ISO seeks solution summary and proposal submissions for projects that fall within the scope of the ARPA-H mission Resilient Systems Office (RSO). RSO’s interest areas will address systemic challenges across the healthcare and public health landscape by investing in cutting-edge technologies that address long-standing gaps in the quality, efficacy, and consistent availability of care. Aspects of today’s health and public health systems remain fragile due to systemic challenges, which include rising healthcare costs, inadequate healthcare coverage for significant populations, outdated infrastructure, and health disparities among different demographic groups. Acute challenges, such as hospital closures, supply chain disruptions, staffing shortages, cyber-attacks, public health crises, and the emergence of new diseases, further exacerbate existing fragilities, making it more difficult to maintain high standards of care. These challenges are compounded by the fact that systems remain fragmented, hindering the ability to gain comprehensive insights, make informed decisions, develop tailored interventions, and share critical health information between stakeholders. RSO seeks solution summaries and proposals that drive innovations to enhance the adaptability, reliability, and interoperability of the health ecosystem. Of interest are innovations that foster flexibility and enable adaptation to system stressors, so that people and systems remain well-positioned to deliver high-quality care and improve health outcomes. The following interest areas categorize the ground-breaking research we seek to support: Sociotechnical System Innovation: • Innovate user-centric digital health tools, platforms, technologies, and intervention models that improve outcomes across the health continuum, including prevention, diagnosis, and treatment of physical, mental, and behavioral health. • Approaches to build trust in the healthcare system and distribute high-quality health guidance in an understandable manner that improves patient outcomes. • Novel real-time measurement tools to track health outcomes, evaluate post-market performance of new interventions, and enable convergence on the most effective strategies to improve the quality of care, especially for underserved communities. • Other population centered innovations to create more resilient communities and subpopulations.
Who has won ADVANCED RESEARCH PROJECTS AGENCY for HEALTH (ARPA-H) grants before
From fiscal 2021 to 2025, ADVANCED RESEARCH PROJECTS AGENCY for HEALTH (ARPA-H) (93.384) awarded $524 million across 42 grant awards, an average of $12.5 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Regents of the University of California, San Francisco | California | 3 | $51.9 million |
| Vanderbilt University Medical Center | Tennessee | 2 | $39.8 million |
| University of Washington | Washington | 2 | $38.9 million |
| William Marsh Rice University | Texas | 2 | $35.4 million |
| Emory University | Georgia | 2 | $33.7 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is ARPA-H-SOL-24-103 still open?
No. It closed on March 14, 2025.
Who can apply for Resilient Systems Office: Office-Wide Innovative Solutions Opening for Advanced Research Projects Agency for Health?
Advanced Research Projects Agency for Health accepted applications from nonprofits, colleges and universities, tribes, small businesses and businesses.
What is the deadline for Resilient Systems Office: Office-Wide Innovative Solutions Opening for Advanced Research Projects Agency for Health?
Closed March 14, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has won ADVANCED RESEARCH PROJECTS AGENCY for HEALTH (ARPA-H) grants before?
The largest recipients over five fiscal years were The Regents of the University of California, San Francisco, Vanderbilt University Medical Center, University of Washington. The program made 42 awards worth $524 million in that time.
Similar open grants
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)